Abstract. The Portable Neuromodulation Stimulator (PoNS) is a compact, self-contained device that delivers a xed sequence of dc-balanced voltage pulses to the anterior-dorsal tongue through a matrix of 143 gold-plated electrodes. This form of stimulation is being investigated as a possible aid to rehabilitation of motor, cognitive, and emotional symptoms resulting from a range of neurological disorders of traumatic, degenerative, or developmental origin. This article provides a technical overview of the PoNS device as well as a summary of applications research to date.
Introduction
This paper describes the theory, design, and application of the Portable Neuromodulation Stimulator (PoNS; Figure 1 ), a device developed by the author in 2008 to facilitate collaborative studies examining the e ects of comfortable electrical stimulation of the tongue on the e cacy of neurorehabilitation exercises. Some design elements of the PoNS device are based on the earlier Tongue Display Unit (TDU; Figure 1 ), which is a general-purpose, programmable platform for investigation of tongue electrotactile psychophysics as well as for development of potential applications of tactile information display on the tongue [1] [2] [3] . A full technical description of the TDU, as well as a summary of research using it, appears in [4] .
The conceptual framework leading to PoNS development resulted from adventitious observations using the TDU, which, unlike the PoNS device, could modulate the tongue stimulation in real time in response to external inputs. about the anterior-posterior and lateral-medial axes was mapped to a spatially-corresponding electrotactile stimulus on the ventral tongue surface of vestibularimpaired individuals, not only immediate postural stability improvement was observed, but also a longerterm (minutes to months) balance improvement, even after the apparatus was removed from the mouth [5, 6] . Subsequent technology license resulted in the BrainPort balance and vision sensory substitution devices by Wicab, Inc. (http://www.wicab.com). The TDU itself was never commercialized. The sustained bene ts of tongue-based sensory substitution lead to the question of whether the supplemental balance information is necessary, or whether the electrotactile stimulus alone on the tongue may be bene cial. Indeed, independent experiments at the University of Wisconsin-Madison have revealed that balance exercises combined with whole-array tongue stimulation (with no modulation based on head position or any other exogenous variable) lead to both longterm balance improvement (greater than that typically observed by exercises alone) as well as normalization of activity in brain circuits responsible for postural control [7] [8] [9] [10] [11] [12] [13] [14] [15] . Collectively these results, using both the TDU (programmed to deliver steady, unmodulated tongue stimulation) and the similar stimulation us- ing the PoNS device, suggest that information-devoid tongue stimulation appears to improve the e ects of the exercises via bene cial neuroplasticity. Selected results from these studies appear later in this paper.
Given the size, fragility, and operational complexity of the TDU, we developed the PoNS family of devices as a platform to examine the mechanisms of recovery and optimization of methods combining tongue stimulation and therapeutic exercises. This has also enabled expanding interventions into the homes of subjects by providing each with a PoNS device during the study. Because the TDU and PoNS share several similarities, emphasis will be given to features and characteristics speci c to the latter. In particular, the PoNS device delivers only one kind of waveform and delivers it to all of the electrodes; this allows the PoNS device to be much smaller and simpler than the TDU, which provides for individual control of stimulation on each electrode.
To date, two major PoNS versions have been deployed, the rst with a square matrix of 144 electrodes and the second with a heart-shaped matrix of 143 electrodes arranged in a hexagonal pattern. PoNS versions 1 and 2 are laboratory tools intended for investigational purposes only.
A PoNS device pending regulatory approval for commercial deployment as a medical device is under development and testing by NeuroHabilitation Corporation. Although its principle of operation is similar to that of the devices described here, its technical details are proprietary and only versions 1 and 2 of the PoNS devices are considered in the remainder of this paper.
Theory of operation

Waveforms
The PoNS device delivers repeating positive, capacitively-coupled, voltage-controlled pulses to the dorsal surface of the tongue via a matrix of gold-plated electrodes. Figure 2(a) shows the pulse sequence, xed in hardware, that is delivered by each of the 16 waveform generator channels. Each channel delivers a pulse every 5 ms with each fourth pulse removed. This 3-pulses-per-burst structure (i.e., the bursts repeating every 20 ms) results in a comfortable, buzz-like tactile sensation that is presumed, based on earlier research [16] , to have less sensory adaptation than a steady stream of pulses, although this conjecture has never been explicitly tested. The pulse sequence for each of the 16 channels begins 5 ms/16 = 312.5 s after the sequence starts for the previous channel, evenly staggering the channels in time. In summary, the 16 channels in aggregate deliver 2,400 pulses every second with underlying frequencies (excluding Fourier harmonics from the rectangular pulse shape) of 50/s and 200/s (burst and pulse rates, respectively, per channel) and 3,200/s (representing the inter-channel delay).
Electrodes
For the PoNS device version 1, the 12 12 square electrode array is subdivided into nine 4 4 blocks (Figure 3) , each block mapping in a raster-scanned manner to the 16 waveform generator channels. Therefore, each channel connects directly to nine electrodes that are simultaneously pulsed. This particular scanning order provides that each electrode stimulated should be separated from the nearest pulsed electrode by three electrodes that are unpulsed and serve as the return current path (see Section 2.3). Such separation is important to minimize potential spatial summation e ects, in which current from closely-spaced electrodes may combine to activate the same a erent nerve bers and potentially reduce e ective spatial resolution.
The PoNS version 2 electrode array ( Figure 4 ) is shaped to t more comfortably into the mouth than the version 1 array and enable easier swallowing of saliva. Because the version 2 array is irregularly shaped, the mapping of each channel to the electrode array is likewise irregular. As discussed previously [16] , the particular order of scanning is probably not critical, although an attempt is made to spatially separate simultaneously-and adjacently-pulsed electrodes as much as possible as discussed above.
Two other electrical features distinguish the version 2 array. First, because there are only 143 electrodes, channel 16 maps to only 8 rather than to 9 electrodes. Second, based on previous research showing that the electrotactile sensitivity of the tongue is not spatially uniform [17] , a network of voltagedivider resistors ( Figure 4 ) is inserted between each channel of the waveform generator and the corresponding electrodes. Combined with the electrode resistance (see Section 4), this voltage-divider network reduces the pulse amplitude at the more-sensitive tip and sides of the tongue, resulting in a tactile sensation that is more spatially uniform than for a matrix (such as that on PoNS version 1) receiving the same potential on all electrodes. Figure 4 illustrates the four resulting stimulation levels.
The end result of this electrode activation pattern is that the tongue receives 25,920,000 (version 1) or 25,740,000 (version 2) stimulation pulses during a typical 20-min therapy session. It is still unknown how many action potentials on a erent nerves innervating the tongue are generated by this stimulation and, furthermore, what activity they elicit in their brainstem projections. Both ngertip and lingual cutaneous mechano-a erent bers can sustain ring rates greater than 200 pulses/s in response to mechanical stimuli [18, 19] ; data for repetitive electrical stimulation are sparse.
While the sublingual electric eld distribution is likewise not well known, some reasonable bounds may be established. Surface electrode eld penetration is on the same order of magnitude as interelectrode spacing ( [20] , p. 134), in this case approximately. 1 mm. The PoNS array eld probably penetrates somewhat deeper than this owing to the relatively high resistance of the return pathway via unpulsed electrodes, relative to the highly-conductive sublingual tissue (cf. [21] , Chap. 2), returning a greater proportion of current to non-adjacent electrodes and, therefore, leading to e ectively greater inter-electrode spacing. Although such deeper penetration might be expected to stimulate the intrinsic tongue muscles, no obvious twitching has been observed to date. Figure 5 illustrates the key components of the waveform generator output circuit. Although the part values are di erent, the essential functionality is very similar to that for the TDU and, therefore, an abbreviated summary is provided here. An analog multiplexer (Mux) distributes a xed 19-V potential to one of the sixteen output channels according to timing signals to its address and enable lines (not shown). These timing signals are generated by simple clock/timer/counter components.
Output circuit
A 1-F capacitor in series with each multiplexer output slightly shifts the mean output voltage so that the net direct current into the tongue electrode is extremely small (less than 1 A, the lower limit of the author's measurement equipment), minimizing the potential for tongue irritation. Such irritation has not Figure 2 . The capacitor provides dc blocking; the 1-k resistor provides the return current path for unpulsed electrodes, and the 100-k resistor establishes the dc operating point (see text). The internal \on" resistance of the multiplexer is approximately 130 .
been reported in ve years of using PoNS technology with human subjects, although a prospective long-term study has not yet been performed. This capacitance value represents a compromise between minimizing the dV=dt voltage droop during each pulse (see Section 4) and limiting the maximal charge pulse to 19 C, much lower than the 500-C upper limit recommended by Underwriters Laboratories (UL) for a 1-F capacitive discharge ( [22] , Figure 11 Because the electrode array has no ground plane [23] , and because inactive multiplexer outputs are open circuit, the 1-k resistors provide the return current path (through the inactive electrodes and capacitors). The 100-k resistors serve to stabilize the dc operating point and ensure zero mean voltage at the electrodes, but do not otherwise signi cantly a ect the stimulation waveform.
User interface
The PoNS devices versions 1.X and 2.X have two momentary-contact push buttons for power on and power o functions. Colored lights indicate battery status (normal/low) and charge status (charging/charged). Nominal battery life is 3-4 h. The internal lithium-polymer battery pack is charged with an external dc power supply that plugs into the AC mains and into the side of the PoNS unit. The PoNS device automatically turns o while being charged to prevent corded use.
Stimulation intensity control is managed di erently for each PoNS version. For version 1 the user manipulates a potentiometer, which adjusts the opencircuit pulse amplitude (voltage) from 0 to 17 V, while the pulse width is xed at 50 s. For versions 2.1 and 2.2 the user manipulates the pulse width (0.4-60 s) using a pair of UP/DOWN pushbuttons in 64 uneven increments, while the open-circuit pulse amplitude is 19 V. Owing to the strength-duration relationship for physiological nerve stimulation, pulse amplitude or pulse width changes feel similar to the user, although minor di erences in ber recruitment patterns may be possible [24] .
The PoNS device version 2.5 is programmable; pulse width automatically ramps up from a minimum to a maximum value that may be set using a simple software application on an external computer. This allows more precise control over physical stimulus levels for human subjects experiments. One limitation of such xed levels is that the perceived level of stimulation may vary from session to session with changes in the subject's individual sensitivity to the stimulation. 4 . Electrical performance Figure 6 shows the typical voltage (relative to PoNS ground) and current for a representative electrode for each of the four stimulation levels for a PoNS device version 2. The voltage trace departs from a nominallyrectangular shape because the PoNS output circuit has a nite output resistance and because the electrodeskin interface has both resistive and capacitive components [4] . Because of the capacitive component of the electrode impedance, the current exhibits an initial spike followed by an asymptotic decrease. The pulse shape di erence between the four stimulation level current waveforms may be accounted for by the level-setting resistors. For the lower levels, the increasing values of the series level-setting resistors reduce both the initial current spike and the asymptotic current at the end of the pulse.
The electrode voltage waveforms are similarly a ected by the level-setting resistors, but with somewhat more complex dynamics. For Level 1, the electrode voltage shows a relatively rapid asymptotic increase (the rate of which is governed by electrode capacitance), followed by a slow decrease during the pulse (due to the dV=dt droop across the 1-uF capacitor in the driver circuit). For the lower three levels, this droop is obscured by the much slower initial asymptotic increase. This is because of the larger time constant resulting from the series level-setting resistors.
Given the above comments, we would expect the a erent stimulation to be driven primarily by the charge delivered during the pulse [25] ; for the four Levels 1, 2, 3, and 4, the areas under the current curve are approximately 124, 93, 70, and 53 nC. These values correspond well with the target percentages shown in Figure 4 (derived from [17] ), the exact distribution among the four levels being dependent on electrode impedance, which itself varies among individuals and is still under study.
Preliminary unpublished data suggest this impedance may be approximately modeled by a 1-k resistance in series with a parallel RC network (4.5 k , 0.5 nF) for the PoNS version 2 electrode array. This is slightly lower than that reported for the TDU electrode array (1 k in series with 5 k k 0:5 nF [4] ), which is geometrically equivalent to the PoNS version 1 array. The greater overall electrode spatial density in the PoNS version 2 hexagonal array may account for this di erence.
Placebo PoNS
Because PoNS stimulation is normally combined with therapeutic exercises [26] , and because the exercises alone may result in bene cial e ects, it is important to determine the relative contribution of each. While ideally we might seek a PoNS \placebo" that may be tested against the \real" device, choosing the characteristics of such a device is not obvious. For example, relative to no device at all, any purported e ect might be argued to result from at least three possible causes:
1. The mechanical e ect of the device in the mouth, resulting in both activation of mechanoreceptive a erents as well as user knowledge that the device is in the mouth; 2. Perception of the electrical stimulation; 3. The electrical stimulus itself, i.e. any e ect of the propagated stimuli (via tongue cutaneous a erents) on brain structures that is not a result of (1) or (2).
We therefore developed two di erent kinds of placebo devices to enable experimental dissection of these purported e ects.
Placebo null
The rst schema, which we call Placebo Null (PN), looks like and appears to function like a normal or \Ac-tive" PoNS device but delivers no electrical stimulation. The device contains working ON and OFF buttons and indicator lights, and non-functional UP and DOWN level buttons. Removal of +19 V excitation to the multiplexer ( Figure 5 ) results in no deliberate electrical signal to the electrodes. On careful measurement, the small \noise" potentials appearing on the electrodes mostly retain the temporal characteristics of the Active device but manifest themselves as rounded pulses that are < 100 ns wide and < 50 mV in amplitude, for e ectively 0.17% of the minimum charge delivered by an Active device (0.3 s, 19 V), and approximately 0.029% of the sensation threshold charge for a typical user. Therefore, the user feels the device in the mouth, but does not feel or receive any e ectual electrical stimulation.
Placebo low
To address a di erent concern, that subjects can feel the electrical stimulation of an Active device but do not feel it for a PN device, we developed the Placebo Low (PL). Similarly to the Active device, the PL device delivers 19-V, 0.3-60-s pulses, which at su cient pulse width are perceivable. This stimulus, however, occurs at an extremely low rate, with each electrode receiving a pulse approximately every 12.5 s. Because the 16 channels evenly divide this period, the user feels a stimulus somewhere on their tongue at a rate of 1.28/s.
To prevent large gaps in the sensation, the pulses occur continuously, without the burst structure used for Active devices (see Figure 2(b) ). The user therefore feels a \tap-tap-tap" stimulus that moves (deterministically but seemingly randomly) around the tongue with the same sequence as for the active device; for any tap, nine electrodes are simultaneously stimulated (eight for Channel 16). Although this is di erent from the vibration-tingle felt for the Active device, the subject clearly knows he or she is receiving electrical stimulation, thereby allowing one to experimentally isolate the e ect of feeling the stimulus. Because of the extremely low pulse rate, only 13,728 pulses are delivered to the array during a 20-min treatment session, or approximately 0.053% relative to Active. Although the dose-response characteristic for PoNS stimulation is unknown and possibly nonlinear, it is reasonable to assume based on this large ratio that any neuromodulatory e ect resulting from cutaneous a erent stimulation is much smaller for PL than for Active devices.
Application to neurorehabilitation
The PoNS device has enabled a number of studies examining the use of tongue stimulation to enhance neurorehabilitation. Those with at least partial results published or presented are brie y summarized next, divided into three categories: etiologies, symptoms, and placebo control. Previous sensory substitution research showed that tongue-based vestibular feedback improved a number of neurological symptoms, including particularly balance and gait, for individuals with a variety of peripheral and central vestibular disorders [5, 6, [27] [28] [29] [30] [31] [32] [33] . This etiology independence suggests that purported bene cial e ects of information-free tongue neurostimulation, such as that delivered by the PoNS device, may similarly be etiology independent. Research in progress has provided initial evidence that this may indeed be the case; e cacy has been observed in preliminary studies investigating multiple sclerosis [34, 35] , traumatic brain injury [36] [37] [38] [39] [40] [41] , stroke [41] [42] [43] [44] [45] [46] , Parkinson's disease [47, 48] spinal cord injury [49] , and posterior fossa syndrome [50] .
The preliminary e cacy of PoNS stimulation and related therapeutic exercises have also been observed across a variety of symptoms including not only balance and gait (above) but also control of eye movements [38, 42, 44, 48, 51, 52] , muscle activation patterns [36] [37] [38] , cognitive function [34, 37] , self-reports of sleep, bowel and bladder function, concentration, and tremor [53] . These observations, coupled with results across etiologies above, have led to formulation of a conceptual framework for generalized neurorehabilitation called cranial-nerve noninvasive neuromodulation, or CN-NINM [26, [54] [55] [56] [57] .
A limitation of most of the studies cited above is lack of a control group. One controlled study, however, showed that gait in a group of individuals with moderate (cane/walker) stage multiple sclerosis improved more for a group of 10 subjects using an active PoNS device than for a control group of 10 subjects using a Placebo Null PoNS device [35] . This bene t extended into the 12-week at-home phase of the study following the 2-week in-lab phase, showing the potential for home-based PoNS therapy. Because both groups received the bene t of balance and gait exercises as well as any purported psychological bene t of having a PoNS device in their mouth, it would appear that the electrical stimulus in the active group resulted in the di erence. Because, however, the active group felt the stimulus and the control group did not, it is not yet possible (on the basis of the intergroup di erence) to di erentiate between a potential psychological bene t of feeling the stimulation and a potential neurological bene t of subjects receiving the stimulation. The Placebo Low PoNS device will help to resolve this question, and is included in a study currently in progress at the University of WisconsinMadison investigating rehabilitation of balance and gait in mild-to-moderate traumatic brain injury.
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